Armis Centrix™ for VIPR is a commercial vulnerability assessment tool by Armis. Conviso Vuln Intelligence is a commercial vulnerability assessment tool by Conviso. Compare features, ratings, integrations, and community reviews side by side to find the best vulnerability assessment fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
Healthcare mid-market and enterprise teams that need vulnerability management tied directly to patient safety,not just IT risk,should run Armis Centrix for VIPR. Its Clinical Impact Score reorders remediation by actual clinical consequence rather than CVSS score alone, a distinction that matters when you have 10,000 medical devices and three remediation slots. The platform covers NIST ID.AM and ID.RA solidly, with real-time device inventory and threat intelligence, though it leans toward asset visibility over response automation; this is a prioritization engine first, not a ticketing replacement. Wrong tool if your infrastructure team wants device management divorced from clinical context or needs deep integration with your existing vulnerability scanner output.
Mid-market and enterprise security teams drowning in scanner sprawl should pick Conviso Vuln Intelligence for its deduplication and risk-based prioritization engine, which actually reduces noise instead of just aggregating it. The platform covers asset management, continuous monitoring, and supply chain risk assessment across NIST CSF 2.0, and the automatic SBOM generation saves weeks of compliance legwork. Skip this if your org runs fewer than three vulnerability scanners or needs deep incident response forensics; Conviso is built for triage and lifecycle management, not post-breach investigation.
Healthcare-focused vuln mgmt platform for medical device security & risk prioritization
Risk-based vuln mgmt platform centralizing findings from multiple scanners
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing Armis Centrix™ for VIPR vs Conviso Vuln Intelligence for your vulnerability assessment needs.
Armis Centrix™ for VIPR: Healthcare-focused vuln mgmt platform for medical device security & risk prioritization. built by Armis. headquartered in United States. Core capabilities include Real-time medical device inventory and visibility, Vulnerability detection and deduplication, Clinical Impact Score for patient safety prioritization..
Conviso Vuln Intelligence: Risk-based vuln mgmt platform centralizing findings from multiple scanners. built by Conviso. headquartered in Brazil. Core capabilities include Risk-based vulnerability prioritization, Multi-scanner integration and findings correlation, Vulnerability deduplication..
Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.
Get strategic cybersecurity insights in your inbox